Skip to main content
Top
Published in: Pediatric Cardiology 6/2023

08-04-2023 | Patent Ductus Arteriosus | Research

Hemodynamic and Echocardiographic Characteristics and the Presence of Pulmonary Hypertension in Patent Ductus Arteriosus Patients who Underwent Transcatheter Closure

Authors: Po-Wei Wu, Shu-Jen Yeh, Pi-Chang Lee, Ke-Ting Pan, Chih-Wei Tien, Yen-Chun Chao, Shan-Miao Lin, Ming-Ren Chen, Wei-Li Hung

Published in: Pediatric Cardiology | Issue 6/2023

Login to get access

Abstract

We investigated the hemodynamic parameters of pediatric PDA patients and focused on the influence of PDA size on pulmonary arterial pressure and the prevalence of pulmonary hypertension. A total of 52 patients aged between 2 months and 20 years who received transcatheter closure of a PDA from January 2018 to June 2022 in our institution were retrospectively recruited. Their hemodynamic parameters collected both by echocardiography and by cardiac catheterization were analyzed to delineate the influence of PDA size on the pulmonary vascular system. The echocardiographic-based ductal size and indexed PDA size were 1.93 mm (1.15–6 mm) and 4.05 mm/m2 (2.03–25.47 mm/m2), respectively. The pulmonary artery pressure measured was 20.83 mmHg (8–45 mmHg). We found a positive correlation between indexed PDA size and mean pulmonary arterial pressure (mPAP) (Pearson correlation coefficient = 0.47, p < 0.001). A subgroup analysis showed that 28 patients (53.8%) developed pulmonary hypertension (PH) (defined as mPAP > 20 mmHg). The median age of the PH group was 1.02 years [range: 0.19–8.64], which was significantly younger than the non-PH group's median age of 3.43 years [range: 0.42–19.96] (p = 0.001). The indexed PDA size for the PH group, 4.69 mm/m2, was significantly higher than that of the non-PH group, 3.2 mm/m2 (p = 0.004). The major risk factor for patients with PH was the PDA/BSA index, with an OR of 2.181 (95% CI, 1.224–3.887). Our demographic data showed younger patients with a higher PDA/BSA index are more likely to develop pulmonary hypertension.
Literature
15.
go back to reference Ruth BK, Bilchick KC, Mysore MM, Mwansa H, Harding WC, Kwon Y, Kennedy JLW, Mazurek JA, Mihalek AD, Smith LA, Mejia-Lopez E, Parker AM, Welch TS, Mazimba S (2019) Increased pulmonary-systemic pulse pressure ratio is associated with increased mortality in group 1 pulmonary hypertension. Heart Lung Circ 28(7):1059–1066. https://doi.org/10.1016/j.hlc.2018.05.199CrossRefPubMed Ruth BK, Bilchick KC, Mysore MM, Mwansa H, Harding WC, Kwon Y, Kennedy JLW, Mazurek JA, Mihalek AD, Smith LA, Mejia-Lopez E, Parker AM, Welch TS, Mazimba S (2019) Increased pulmonary-systemic pulse pressure ratio is associated with increased mortality in group 1 pulmonary hypertension. Heart Lung Circ 28(7):1059–1066. https://​doi.​org/​10.​1016/​j.​hlc.​2018.​05.​199CrossRefPubMed
18.
go back to reference Abman SH, Hansmann G, Archer SL, Ivy DD, Adatia I, Chung WK, Hanna BD, Rosenzweig EB, Raj JU, Cornfield D, Stenmark KR, Steinhorn R, Thébaud B, Fineman JR, Kuehne T, Feinstein JA, Friedberg MK, Earing M, Barst RJ, Keller RL, Kinsella JP, Mullen M, Deterding R, Kulik T, Mallory G, Humpl T, Wessel DL (2015) Pediatric pulmonary hypertension. Circulation 132(21):2037–2099. https://doi.org/10.1161/cir.0000000000000329CrossRefPubMed Abman SH, Hansmann G, Archer SL, Ivy DD, Adatia I, Chung WK, Hanna BD, Rosenzweig EB, Raj JU, Cornfield D, Stenmark KR, Steinhorn R, Thébaud B, Fineman JR, Kuehne T, Feinstein JA, Friedberg MK, Earing M, Barst RJ, Keller RL, Kinsella JP, Mullen M, Deterding R, Kulik T, Mallory G, Humpl T, Wessel DL (2015) Pediatric pulmonary hypertension. Circulation 132(21):2037–2099. https://​doi.​org/​10.​1161/​cir.​0000000000000329​CrossRefPubMed
25.
go back to reference Hansmann G, Koestenberger M, Alastalo TP, Apitz C, Austin ED, Bonnet D, Budts W, D’Alto M, Gatzoulis MA, Hasan BS, Kozlik-Feldmann R, Kumar RK, Lammers AE, Latus H, Michel-Behnke I, Miera O, Morrell NW, Pieles G, Quandt D, Sallmon H, Schranz D, Tran-Lundmark K, Tulloh RMR, Warnecke G, Wåhlander H, Weber SC, Zartner P (2019) 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: the European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT. J Heart Lung Transplant 38(9):879–901. https://doi.org/10.1016/j.healun.2019.06.022CrossRefPubMed Hansmann G, Koestenberger M, Alastalo TP, Apitz C, Austin ED, Bonnet D, Budts W, D’Alto M, Gatzoulis MA, Hasan BS, Kozlik-Feldmann R, Kumar RK, Lammers AE, Latus H, Michel-Behnke I, Miera O, Morrell NW, Pieles G, Quandt D, Sallmon H, Schranz D, Tran-Lundmark K, Tulloh RMR, Warnecke G, Wåhlander H, Weber SC, Zartner P (2019) 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: the European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT. J Heart Lung Transplant 38(9):879–901. https://​doi.​org/​10.​1016/​j.​healun.​2019.​06.​022CrossRefPubMed
30.
go back to reference Kiran VS, Tiwari A (2018) Prediction of left ventricular dysfunction after device closure of patent ductus arteriosus: proposal for a new functional classification. EuroIntervention 13:2124–2129CrossRef Kiran VS, Tiwari A (2018) Prediction of left ventricular dysfunction after device closure of patent ductus arteriosus: proposal for a new functional classification. EuroIntervention 13:2124–2129CrossRef
Metadata
Title
Hemodynamic and Echocardiographic Characteristics and the Presence of Pulmonary Hypertension in Patent Ductus Arteriosus Patients who Underwent Transcatheter Closure
Authors
Po-Wei Wu
Shu-Jen Yeh
Pi-Chang Lee
Ke-Ting Pan
Chih-Wei Tien
Yen-Chun Chao
Shan-Miao Lin
Ming-Ren Chen
Wei-Li Hung
Publication date
08-04-2023

Other articles of this Issue 6/2023

Pediatric Cardiology 6/2023 Go to the issue